Home › NDC Lookup › RxCUI directory › RxCUI 2183907

Dexchlorpheniramine maleate 0.4 MG/ML Oral Solution — RxCUI 2183907

RxNorm drug concept · Semantic clinical drug
RxCUI 2183907 Semantic clinical drug · SCD ● Current RxNorm concept 2 FDA products 4 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI2183907
Official nameDexchlorpheniramine maleate 0.4 MG/ML Oral Solution
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asdexchlorpheniramine 2 MG per 5 ML Oral Solution; dexchlorpheniramine maleate 2 MG in 5 mL Oral Solution
FDA products mapped2
Package NDCs mapped4
Reported Medicaid activity (SDUD)1,898 prescriptions · 2 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

🕸️ Concept Web — How Dexchlorpheniramine maleate 0.4 MG/ML Oral Solut... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Dexchlorpheniramine maleate 0.4 MG/ML Oral Solution RxCUI 2183907

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 2

    The active substance itself — no strength, form, or brand attached yet.

    • Dexchlorpheniramine 22697
    • Dexchlorpheniramine maleate 54828
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Ryclora 2058851
  3. Dose forms 13

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Dexchlorpheniramine Oral Solution 371742
    • Dexchlorpheniramine maleate Oral Solution 2646894
    • Dexchlorpheniramine Oral Liquid Product 1157797
    • Dexchlorpheniramine Oral Product 1157798
    • Dexchlorpheniramine maleate Oral Liquid Product 2663212
    • Dexchlorpheniramine maleate Oral Product 2663105
    • Dexchlorpheniramine Oral Solution [Ryclora] 2058853
    • Dexchlorpheniramine maleate Oral Solution [Ryclora] 2655584
    • +5 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 14 of 19 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Dexchlorpheniramine maleate 0.4 MG/ML SCDC · 1357939
  • Dexchlorpheniramine Oral Solution SCDF · 371742
  • Dexchlorpheniramine maleate Oral Solution SCDFP · 2646894
  • Dexchlorpheniramine Oral Liquid Product SCDG · 1157797
  • Dexchlorpheniramine Oral Product SCDG · 1157798
  • Dexchlorpheniramine maleate Oral Liquid Product SCDGP · 2663212
  • Dexchlorpheniramine maleate Oral Product SCDGP · 2663105

Brand-Name Concepts

  • Dexchlorpheniramine maleate 0.4 MG/ML Oral Solution [Ryclora] SBD · 2183912
  • Dexchlorpheniramine maleate 0.4 MG/ML [Ryclora] SBDC · 2183911
  • Dexchlorpheniramine Oral Solution [Ryclora] SBDF · 2058853
  • Dexchlorpheniramine maleate Oral Solution [Ryclora] SBDFP · 2655584
  • Ryclora Oral Liquid Product SBDG · 2058854
  • Ryclora Oral Product SBDG · 2058855
  • Ryclora BN · 2058851

📦 FDA Products & Package NDCs

2 products · 4 package NDCs
4 package NDCs map to RxCUI 2183907 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
15370-0150-04 118 mL in 1 BOTTLE, PLASTIC (15370-150-04) RYCLORA CARWIN PHARMACEUTICAL ASSOCIATES, LLC 2018-10-07
15370-0150-16 473 mL in 1 BOTTLE, PLASTIC (15370-150-16) RYCLORA CARWIN PHARMACEUTICAL ASSOCIATES, LLC 2018-10-07
15370-0150-99 20 mL in 1 BOTTLE, PLASTIC (15370-150-99) RYCLORA CARWIN PHARMACEUTICAL ASSOCIATES, LLC 2018-10-07
73684-0300-08 237 mL in 1 BOTTLE, PLASTIC (73684-300-08) Corphena BluCrest Pharmaceuticals LLC 2025-12-22
Observed labelers: CARWIN PHARMACEUTICAL ASSOCIATES, LLC (3) · BluCrest Pharmaceuticals LLC (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.